These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23588948)

  • 21. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.
    Sun CY; Zang YC; San YX; Sun W; Zhang L
    Saudi Med J; 2010 May; 31(5):525-32. PubMed ID: 20464042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.
    Dagher J; Dugay F; Rioux-Leclercq N; Verhoest G; Oger E; Bensalah K; Cabillic F; Jouan F; Kammerer-Jacquet SF; Fergelot P; Vigneau C; Arlot-Bonnemains Y; Belaud-Rotureau MA
    Hum Pathol; 2014 Aug; 45(8):1639-46. PubMed ID: 24856572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
    Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
    Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.
    Zhang Z; Li J; Zheng H; Yu C; Chen J; Liu Z; Li M; Zeng M; Zhou F; Song L
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2685-93. PubMed ID: 19755649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implication of TIM-3 in clear cell renal cell carcinoma.
    Yuan J; Jiang B; Zhao H; Huang Q
    Neoplasma; 2014; 61(1):35-40. PubMed ID: 24195506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma.
    Guo CC; Zhang XL; Yang B; Geng J; Peng B; Zheng JH
    Mol Med Rep; 2014 Jun; 9(6):2367-73. PubMed ID: 24676838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma.
    Zheng J; Wang L; Peng Z; Yang Y; Feng D; He J
    EBioMedicine; 2017 Feb; 15():62-72. PubMed ID: 27993630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of caspase 7 expression is associated with poor prognosis in renal cell carcinoma clear cell subtype.
    Vilella-Arias SA; Rocha RM; da Costa WH; Zequi Sde C; Guimarães GC; Verjovski-Almeida S; Soares FA; Reis EM
    Urology; 2013 Oct; 82(4):974.e1-7. PubMed ID: 23920448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker.
    Qi Y; Zhang Y; Peng Z; Wang L; Wang K; Feng D; He J; Zheng J
    J Cell Mol Med; 2018 Feb; 22(2):1224-1235. PubMed ID: 29239102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues.
    Vieira de Ribeiro AJ; Sandim V; Ornellas AA; Reis RS; Domont G; Alves G
    Int Braz J Urol; 2013; 39(1):83-94. PubMed ID: 23510786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma.
    Lee HJ; Kim DI; Kang GH; Kwak C; Ku JH; Moon KC
    Urology; 2009 Feb; 73(2):394-9. PubMed ID: 18849062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
    Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and role of vascular endothelial growth inhibitor in sporadic clear cell renal cell carcinoma].
    Wu LY; Cheng H; Deng XH; Shan H; Wang W; Yang Y; Zhang XD; Zhang N
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):741-5. PubMed ID: 23755810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD151 expression can predict cancer progression in clear cell renal cell carcinoma.
    Yoo SH; Lee K; Chae JY; Moon KC
    Histopathology; 2011 Jan; 58(2):191-7. PubMed ID: 21323946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma.
    Ye YW; Jiang ZM; Li WH; Li ZS; Han YH; Sun L; Wang Y; Xie J; Liu YC; Zhao J; Tang AF; Li XX; Guan ZC; Gui YT; Cai ZM
    Neoplasma; 2012; 59(6):599-605. PubMed ID: 22862160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.
    Rabjerg M; Oliván-Viguera A; Hansen LK; Jensen L; Sevelsted-Møller L; Walter S; Jensen BL; Marcussen N; Köhler R
    PLoS One; 2015; 10(4):e0122992. PubMed ID: 25848765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of CIP2A in clear cell renal cell carcinoma promotes cellular epithelial-mesenchymal transition and is associated with poor prognosis.
    Tang Q; Wang Q; Zeng G; Li Q; Jiang T; Zhang Z; Zheng W; Wang K
    Oncol Rep; 2015 Nov; 34(5):2515-22. PubMed ID: 26327467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of oxidative stress proteins in the clear-cell renal cell carcinoma].
    Tian MJ; Li YY; Luo CQ; Lv ML; Yang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):851-5. PubMed ID: 22863595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.